Euglycemic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor

被引：2

作者：

Koch, Richard A. ^{[1
]}

Clark, Richard F. ^{[1
]}

机构：

[1] Univ Calif San Diego, Dept Emergency Med, Div Med Toxicol, San Diego, CA 92103 USA

来源：

AMERICAN JOURNAL OF THERAPEUTICS | 2018年 / 25卷 / 05期

关键词：

SGLT2; INHIBITORS;

D O I：

10.1097/MJT.0000000000000602

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：E590 / E591

页数：3

共 9 条

[1] Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion [J].

Bonner, Caroline ;

Kerr-Conte, Julie ;

Gmyr, Valery ;

Queniat, Gurvan ;

Moerman, Ericka ;

Thevenet, Julien ;

Beaucamps, Cedric ;

Delalleau, Nathalie ;

Popescu, Iuliana ;

Malaisse, Willy J. ;

Sener, Abdullah ;

Deprez, Benoit ;

Abderrahmani, Amar ;

Staels, Bart ;

Pattou, Francois .

NATURE MEDICINE, 2015, 21 (05) :512-U139

[2]

FDA Drug Safety Communication, FDA REV LAB SGLT2 IN

[3]

John Mathew, 2016, Indian J Endocrinol Metab, V20, P22, DOI 10.4103/2230-8210.172268

[4]

Lu Y, 2014, FRONT PHARMACOL, V5, P1

[5] Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors: possible mechanism and contributing factors [J].

Ogawa, Wataru ;

Sakaguchi, Kazuhiko .

JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (02) :135-138

[6] Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition [J].

Peters, Anne L. ;

Buschur, Elizabeth O. ;

Buse, John B. ;

Cohan, Pejman ;

Diner, Jamie C. ;

Hirsch, Irl B. .

DIABETES CARE, 2015, 38 (09) :1687-1693

[7] Metabolic effects of SGLT-2 inhibitors beyond increased glucosuria: A review of the clinical evidence [J].

Scheen, A. J. ;

Paquot, N. .

DIABETES & METABOLISM, 2014, 40 :S4-S11

[8] Sodium-glucose cotransporter-2 inhibitor combination therapy to optimize glycemic control and tolerability in patients with type 2 diabetes: focus on dapagliflozin-metformin [J].

Schwartz, Stanley S. ;

Katz, Arie .

DIABETES METABOLIC SYNDROME AND OBESITY, 2016, 9 :71-82

[9] SGLT2 Inhibitors May Predispose to Ketoacidosis [J].

Taylor, Simeon I. ;

Blau, Jenny E. ;

Rother, Kristina I. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (08) :2849-2852

← 1 →